11/21/2011 - 2:42pm

Many so-called restricted-network Medicare Part D prescription drug plans don't give adequate pharmacy access to rural residents and are deceptively marketed to patients, the National Community Pharmacists Association said Monday.

11/21/2011 - 1:51pm

Drug maker Impax Labs is looking to challenge the patent protection on a drug used to treat pain related to cancer, the company said Monday.

11/21/2011 - 1:48pm

Mylan will begin selling a generic drug for treating symptoms of menopause in two years, the company said Monday.

11/21/2011 - 12:59pm

After being unanimously recommended for approval by a Food and Drug Administration panel, the FDA has approved an eye disorder treatment created by Regeneron Pharmaceuticals.

11/18/2011 - 3:32pm

NACDS and NCPA announced that they have sent joint letters to the Joint Select Committee on Deficit Reduction and the U.S. Senate Armed Services Committee, encouraging the rejection of an Obama administration proposal that would “saddle Tricare beneficiaries with higher prices and penalize their utilization of community pharmacists.”

11/18/2011 - 11:48am

A drug widely used to treat breast cancer is not safe or effective, the Food and Drug Administration said Friday.

11/18/2011 - 11:01am

The Food and Drug Administration has approved a new chemotherapy drug for treating acute lymphoblastic leukemia, the agency said Friday.

11/17/2011 - 4:24pm

The National Association of Chain Drug Stores has announced that the dates of the 2012 NACDS RxImpact Day on Capitol Hill in Washington, D.C., have been changed because of an alteration in the 2012 congressional calendar.

11/16/2011 - 4:36pm

When its blockbuster cholesterol drug Lipitor loses patent protection this month, Pfizer is hoping that pharmacy benefit managers will not dispense a generic version of the drug to its customers, according to published reports.